Today on in-pharmatechnologist.com
 
Double whammy as Merck kids' vaccines recalled and suspended

China's API manufacturers facing further crackdowns

Pharmaceutical manufacturing: news in brief

Novartis launches initiative with 2,500 job losses

West Pharma unit to suffer in post-Exubera fallout

 
   
Related Industry News
 
Biogen Idec shares nosedive after withdrawing 'for sale' sign

Biomarker detection gets 'sticky'

New cell line to tackle drug resistant cancer

Mini synchrotron to ease structural analysis?

 
 
GoIndustry

Pharmaceutical & technology

In association with
PharmaPack
Breaking News on Pharmaceutical Technology
Daily  Friday 14 December 2007 Forward to a colleague

Seminar Info

IPEC Europe's 2008 seminar - Jan 31, 2008Premier event for excipient manufacturers and end-users

Europe's only dedicated forum on issues affecting the excipients sector is just two months away. Don't miss your chance to hear the latest on key topics such as supply chain integrity, counterfeiting, excipient master files and REACH... Click Here

Access Full Stories



Double whammy as Merck kids' vaccines recalled and suspended
Merck has been hit with a contamination threat prompting the recall of a million of its childhood Hib vaccines across the US, right alongside the Canadian suspension of its MMR vaccine... Read


China's API manufacturers facing further crackdowns
The first steps in tightening the safety controls on the pharmaceutical ingredients imported to the US from China have been taken following months of negotiations between the regulatory bodies of the two countries... Read


Pharmaceutical manufacturing: news in brief
In-PharmaTechnologist.com brings you a selection of recent headlines from around the pharmaceutical manufacturing industry... Read


Novartis launches initiative with 2,500 job losses
Novartis is to sever a further 2,500 jobs as part of a new initiative aimed to 'improve competitiveness in a dynamically changing healthcare environment'... Read


West Pharma unit to suffer in post-Exubera fallout
The repercussions of Pfizer's dramatic Exubera exit are finally filtering through to West Pharmaceutical Services, with the company preparing to restructure its affected Tech Group contract manufacturing unit... Read


All News Headlines for:
December | November | October

MarchesiniProduct Brochure

Maximum flexibility and high speed with the new MCPV850.

Presenting the first Marchesini case packer & palletiser to have a vertical case packer, combining in a single compact block the two operations consisting of vertical case packing and palletizing... Click Here

 Advertisement

FineFoods
Related Industry News



Biogen Idec shares nosedive after withdrawing 'for sale' sign
Like countless pets after every Christmas, it seems that nobody wanted Biogen Idec after all; the firm has announced it will remain independent after it 'did not receive any definitive offers to purchase the company'... Read


Biomarker detection gets 'sticky'
US researchers have developed a fast and inexpensive protein biomarker detection device that could simplify disease diagnosis and aid in following disease progression in drug trials... Read


New cell line to tackle drug resistant cancer
The creation of a new 'super cell' that can stand firm against one of the newest types of cancer therapy could shed new light on how to treat patients if they become resistant to these drugs... Read


Mini synchrotron to ease structural analysis?
Researchers have developed a miniature synchrotron that could enable researchers to conduct protein crystallography experiments in their own university and 'revolutionise the way science is done'... Read


Weekly Comment

Paediatric drugs and testing highlighted

The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego. Read



AvevaApplication Note

Transdermal Sufentanil Licensing Opportunity

Aveva's 7-day sufentanil's advanced technology and patient benefits will enable Aveva and its Partner to capture a significant share of the existing $3.9 billion dollar chronic pain market... Click Here
Previous Headlines



Novozymes and Millipore to supply cell culture supplements
Novozymes and Millipore are to supply animal-free cell culture supplements to the biopharmaceutical industry... Read


Pharmaceutical patent round-up
In-PharmaTechnologist.com brings you an update of pharmaceutical patent litigations... Read


Pharmaceutical manufacturing: people on the move
Vyteris, Sciele Pharma, Nektar Therapeutics, Fundamental Applied Biology and Artes Medical have all had people on the move in the world of pharmaceutical manufacturing... Read


BioWa and Lonza agreement for potent antibodies
BioWa and Lonza are joining forces to develop a new technology platform to produce more potent antibodies with enhanced cell-killing powers... Read


NNE wins Pronova contract
NNE Pharmaplan has won a contract with Pronova BioPharma to build the company's new pharma production facility in Kalundborg, Denmark... Read

Technical / White Papers, Case studies, Web casts
Shop floor integration at Novartis Singapore - Case Study

Sensitive and selective with IC-MS coupling - Technical / White Paper



Product Information - brochures, Web centers
Transdermal Sufentanil Licensing Opportunity - Application Notes

Reproducible, homogeneous dry dispersions by the Morphologi® - Application Notes

A Review of Dissolution tests with the Flow Through Method - Application Notes



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Cleanroom, safety equipment, supplies
Contract services (outsourcing)
Drug delivery systems
Ingredients, excipients and raw materials
IT solutions
Lab equipment & consumables
Packaging machinery & supplies
Processing (automation, control, separation...)
QA/QC & validation
Tabletting, coating & ancillary equipment




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@In-PharmaTechnologist.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com